Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)
Close on Nov 17, 2026Market cap $8.03BP/E –Yield –
Rhythm Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Rhythm Pharmaceuticals's market cap was $7.72B on Nov 11, 2026, against $7.27B a year earlier. Over the last 5 years it ranged from $173.35M to $7.72B, with a median of $2.72B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.72B | +8.1% |
| 2025 | Dec 31, 2025 | $7.14B | +107.5% |
| 2024 | Dec 31, 2024 | $3.44B | +26.6% |
| 2023 | Dec 29, 2023 | $2.72B | +67.3% |
| 2022 | Dec 30, 2022 | $1.62B | +223.6% |
| 2021 | Dec 31, 2021 | $501.68M | -61.8% |
| 2020 | Dec 31, 2020 | $1.31B | +65.5% |
| 2019 | Dec 31, 2019 | $793.92M | -14.1% |
| 2018 | Dec 31, 2018 | $924.20M | +1696.5% |
| 2017 | Dec 29, 2017 | $51.44M | – |
See a number that looks wrong?